PAI
ProQuest Associates IV Portfolio holdings
AUM
$53M
This Quarter Return
+24.59%
1 Year Return
+3.35%
3 Year Return
+116.54%
5 Year Return
–
10 Year Return
–
AUM
$518M
AUM Growth
+$518M
(+23%)
Cap. Flow
-$910K
Cap. Flow
% of AUM
-0.18%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
ZSAN
Zosano Pharma Corporation
ZSAN
|
$910K |
Sector Composition
| 1 | Healthcare | 83.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $424M | 81.8% |
4,780,188
| – | – |
|
|
AGRX
2
DELISTED
Agile Therapeutics, Inc
AGRX
| $45.6M | 8.79% |
4,668,663
| – | – |
|
|
IMDZ
3
DELISTED
Immune Design Corp.
IMDZ
| $39.4M | 7.61% |
1,962,720
| – | – |
|
|
ANTH
4
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $8.82M | 1.7% |
1,900,000
| – | – |
|
5
Savara
SVRA
$567M
| $536K | 0.1% |
1,275,925
| – | – |
|
|
ZSAN
6
DELISTED
Zosano Pharma Corporation
ZSAN
| – | – |
-229,759
| Closed | -$910K |
|